Cargando…

Genomic and Immunologic Markers of Intrinsic Resistance to Pembrolizumab Monotherapy in Microsatellite Instability-High Gastric Cancer: Observations from a Prospective Phase II Study

Detalles Bibliográficos
Autor principal: Qiu, Haibo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Georg Thieme Verlag KG 2022
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9192172/
https://www.ncbi.nlm.nih.gov/pubmed/35707777
http://dx.doi.org/10.1055/s-0041-1736237
_version_ 1784726176114147328
author Qiu, Haibo
author_facet Qiu, Haibo
author_sort Qiu, Haibo
collection PubMed
description
format Online
Article
Text
id pubmed-9192172
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Georg Thieme Verlag KG
record_format MEDLINE/PubMed
spelling pubmed-91921722022-06-14 Genomic and Immunologic Markers of Intrinsic Resistance to Pembrolizumab Monotherapy in Microsatellite Instability-High Gastric Cancer: Observations from a Prospective Phase II Study Qiu, Haibo Glob Med Genet Georg Thieme Verlag KG 2022-06-13 /pmc/articles/PMC9192172/ /pubmed/35707777 http://dx.doi.org/10.1055/s-0041-1736237 Text en The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. ( https://creativecommons.org/licenses/by/4.0/ ) https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Qiu, Haibo
Genomic and Immunologic Markers of Intrinsic Resistance to Pembrolizumab Monotherapy in Microsatellite Instability-High Gastric Cancer: Observations from a Prospective Phase II Study
title Genomic and Immunologic Markers of Intrinsic Resistance to Pembrolizumab Monotherapy in Microsatellite Instability-High Gastric Cancer: Observations from a Prospective Phase II Study
title_full Genomic and Immunologic Markers of Intrinsic Resistance to Pembrolizumab Monotherapy in Microsatellite Instability-High Gastric Cancer: Observations from a Prospective Phase II Study
title_fullStr Genomic and Immunologic Markers of Intrinsic Resistance to Pembrolizumab Monotherapy in Microsatellite Instability-High Gastric Cancer: Observations from a Prospective Phase II Study
title_full_unstemmed Genomic and Immunologic Markers of Intrinsic Resistance to Pembrolizumab Monotherapy in Microsatellite Instability-High Gastric Cancer: Observations from a Prospective Phase II Study
title_short Genomic and Immunologic Markers of Intrinsic Resistance to Pembrolizumab Monotherapy in Microsatellite Instability-High Gastric Cancer: Observations from a Prospective Phase II Study
title_sort genomic and immunologic markers of intrinsic resistance to pembrolizumab monotherapy in microsatellite instability-high gastric cancer: observations from a prospective phase ii study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9192172/
https://www.ncbi.nlm.nih.gov/pubmed/35707777
http://dx.doi.org/10.1055/s-0041-1736237
work_keys_str_mv AT qiuhaibo genomicandimmunologicmarkersofintrinsicresistancetopembrolizumabmonotherapyinmicrosatelliteinstabilityhighgastriccancerobservationsfromaprospectivephaseiistudy